Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.62
+0.13 (1.74%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kezar Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -95.78 | -101.87 | -68.24 | -54.63 | -41.74 | -35.09 | Upgrade
|
| Depreciation & Amortization | 1.06 | 1.07 | 1.02 | 1.51 | 1.54 | 1.3 | Upgrade
|
| Other Amortization | 0.25 | 0.24 | 0.21 | 0.09 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | - | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.46 | 2.91 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.66 | -6.83 | -1.4 | 1.77 | 0.32 | -0.98 | Upgrade
|
| Stock-Based Compensation | 12.92 | 18.14 | 14.01 | 7.6 | 4.94 | 4.01 | Upgrade
|
| Other Operating Activities | 0 | 0 | 0.01 | - | - | - | Upgrade
|
| Change in Accounts Payable | -0.65 | 6.35 | 1.81 | 1.22 | 0.31 | 2.21 | Upgrade
|
| Change in Other Net Operating Assets | 0.03 | -1.64 | -6.27 | 0.01 | -2.32 | -1.33 | Upgrade
|
| Operating Cash Flow | -76.37 | -81.65 | -58.85 | -42.44 | -36.95 | -29.88 | Upgrade
|
| Capital Expenditures | -0.02 | -1.81 | -1.58 | -0.32 | -0.19 | -0.61 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | - | Upgrade
|
| Investment in Securities | 84.58 | 77.85 | -89.81 | -28.13 | -56.3 | 21.03 | Upgrade
|
| Investing Cash Flow | 84.56 | 76.05 | -91.39 | -28.44 | -56.5 | 20.42 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 9.53 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 9.53 | - | - | Upgrade
|
| Issuance of Common Stock | 0.12 | 0.64 | 127.86 | 103.05 | 99.64 | 0.27 | Upgrade
|
| Financing Cash Flow | 0.12 | 0.64 | 127.86 | 112.59 | 99.64 | 0.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0 | -0.05 | -0.05 | 0.08 | -0.05 | Upgrade
|
| Net Cash Flow | 8.36 | -4.96 | -22.43 | 41.65 | 6.28 | -9.23 | Upgrade
|
| Free Cash Flow | -76.39 | -83.46 | -60.42 | -42.75 | -37.14 | -30.48 | Upgrade
|
| Free Cash Flow Margin | - | -1192.21% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -10.49 | -11.50 | -8.97 | -8.10 | -8.44 | -15.97 | Upgrade
|
| Cash Interest Paid | 1.32 | 1.32 | 0.97 | 0.07 | - | - | Upgrade
|
| Levered Free Cash Flow | -37.88 | -39.23 | -36 | -22.7 | -21.69 | -17.42 | Upgrade
|
| Unlevered Free Cash Flow | -37.13 | -38.5 | -35.47 | -22.69 | -21.69 | -17.42 | Upgrade
|
| Change in Net Working Capital | -3.67 | -9.88 | 4.44 | -2.68 | 1.14 | -1.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.